Syntax Research, Inc. Globus Medical Inc Transaction History
Syntax Research, Inc.
- $141 Billion
- Q2 2025
A detailed history of Syntax Research, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Syntax Research, Inc. holds 1,000 shares of GMED stock, worth $54,480. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$54,480
Previous $73.2 Million
19.37%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding GMED
# of Institutions
555Shares Held
109MCall Options Held
186KPut Options Held
67.7K-
Vanguard Group Inc Valley Forge, PA10.9MShares$594 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$563 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.01MShares$382 Million0.29% of portfolio
-
State Street Corp Boston, MA3.62MShares$197 Million0.01% of portfolio
-
Burgundy Asset Management Ltd. Toronto, A62.8MShares$153 Million2.22% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $4.2B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...